Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: TPL BK: TPL PLAN OF REORGANIZATION 1-20-14 - Forecast receipts 2014-2020

http://photos.imageevent.com/banos/tplbkplan12014/Exhibit%20B-1%20to%20Disclosure%20Stmt.pdf

TPL is expecting to collect 26 million this year? Is gross receipts the same as revenue? Would this be after the PDS split and Alliacense 20% for MMP related?

Share
New Message
Please login to post a reply